FINWIRES · TerminalLIVE
FINWIRES

Alimentation Couche-Tard Price Target Raised to $106 at RBC

By

RBC Capital Markets raised its price target on Alimentation Couche-Tard Inc. (ATD.TO) to $106 from $104.

Analyst Irene Nattel maintained an Outperform rating on shares of the Canadian multinational convenience store operator following its quarterly results.

The company ended fiscal 2026 with "strong and better than expected KPI's/ financials, notably sequential step-up in US SSS and higher Y/Y GP margins," Nattel said in a note to clients.

"We have been very clear in our view that the key to ATD multiple re-rating is delivering on the financial objectives outlined" at its February investor day, the analyst said.

RBC reiterated a "constructive view on ATD and upside bias to valuation based on improving results, track record of disciplined capital allocation/ability to deliver across cycles."

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Craig Hallum Downgrades Apogee Therapeutics to Hold From Buy, $135.11 Price Target

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $122.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.63, Change: $+42.25, Percent Change: +46.75%

$APGE
Research

Citigroup Downgrades Apogee Therapeutics to Neutral From Buy, Price Target is $135

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $119.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.65, Change: $+42.27, Percent Change: +46.76%

$APGE
Research

Update: Seaport Global Upgrades BWX Technologies to Buy From Neutral, Price Target is $245

(Updates with the analyst's commentary.)Seaport Global upgraded BWX Technologies (BWXT) to buy from neutral, citing the company's acquisition of Precision Components Group after a "strong" fiscal Q1.PCG 2025 revenue was about $125 million and it paid about $200 million for the firm, the brokerage said, citing BWX management.PCG is an authorized nuclear component manufacturer and certified for aerospace and defense quality-management, Seaport said.BWX Technologies has an average rating of overweight and mean price target of $240.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $212.56, Change: $+7.16, Percent Change: +3.49%

$BWXT